[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE0102386D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0102386D0
SE0102386D0 SE0102386A SE0102386A SE0102386D0 SE 0102386 D0 SE0102386 D0 SE 0102386D0 SE 0102386 A SE0102386 A SE 0102386A SE 0102386 A SE0102386 A SE 0102386A SE 0102386 D0 SE0102386 D0 SE 0102386D0
Authority
SE
Sweden
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
SE0102386A
Other languages
Swedish (sv)
Inventor
Ulf Bremberg
Patrizia Caldirola
Gary Johansson
Andrew Mott
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE0102386A priority Critical patent/SE0102386D0/en
Publication of SE0102386D0 publication Critical patent/SE0102386D0/en
Priority to PL02367264A priority patent/PL367264A1/en
Priority to JP2003503591A priority patent/JP4731114B2/en
Priority to IL15859002A priority patent/IL158590A0/en
Priority to AU2002309435A priority patent/AU2002309435B2/en
Priority to CNB028103777A priority patent/CN100457726C/en
Priority to NZ529032A priority patent/NZ529032A/en
Priority to KR1020037016203A priority patent/KR100889718B1/en
Priority to BR0210291-9A priority patent/BR0210291A/en
Priority to EA200400027A priority patent/EA008476B1/en
Priority to KR1020097000129A priority patent/KR20090019894A/en
Priority to EP02778916A priority patent/EP1412325A1/en
Priority to KR1020087016920A priority patent/KR100888906B1/en
Priority to CNA2005101381444A priority patent/CN1800185A/en
Priority to PCT/SE2002/001126 priority patent/WO2002100822A1/en
Priority to YU98003A priority patent/YU98003A/en
Priority to CA002445653A priority patent/CA2445653A1/en
Priority to MXPA03011083A priority patent/MXPA03011083A/en
Priority to US10/167,141 priority patent/US7144883B2/en
Priority to NO20035496A priority patent/NO20035496D0/en
Priority to HK04109896.2A priority patent/HK1066790A1/en
Priority to US11/509,914 priority patent/US20070066598A1/en
Priority to US11/509,989 priority patent/US20070066599A1/en
Priority to US11/510,324 priority patent/US7572787B2/en
Priority to JP2009209444A priority patent/JP2010013473A/en
Priority to US12/781,355 priority patent/US20100222330A1/en

Links

SE0102386A 2001-06-11 2001-07-03 New compounds SE0102386D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
SE0102386A SE0102386D0 (en) 2001-07-03 2001-07-03 New compounds
US10/167,141 US7144883B2 (en) 2001-06-11 2002-06-11 Bicyclic sulfonamide compounds
KR1020087016920A KR100888906B1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ⅱ diabetes
PCT/SE2002/001126 WO2002100822A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
IL15859002A IL158590A0 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
AU2002309435A AU2002309435B2 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes
CNB028103777A CN100457726C (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
NZ529032A NZ529032A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes
KR1020037016203A KR100889718B1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ? diabetes
BR0210291-9A BR0210291A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their preparation and use as a medicament for the treatment of central nervous system disorders, obesity and type II diabetes
EA200400027A EA008476B1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicaments for the treatment of cns disorders, obesity and type ii diabetes
KR1020097000129A KR20090019894A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ⅱ diabetes
EP02778916A EP1412325A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
PL02367264A PL367264A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
CNA2005101381444A CN1800185A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.
JP2003503591A JP4731114B2 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, methods for their use as medicaments for the treatment of CNS disorders, obesity and type II diabetes
YU98003A YU98003A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
CA002445653A CA2445653A1 (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
MXPA03011083A MXPA03011083A (en) 2001-06-11 2002-06-11 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes.
NO20035496A NO20035496D0 (en) 2001-06-11 2003-12-10 Substituted Sulfonamide Compounds, Methods for Their Use as a Drug for the Treatment of CNS Disorders, Overweight and Type II Diabetes
HK04109896.2A HK1066790A1 (en) 2001-06-11 2004-12-14 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
US11/509,914 US20070066598A1 (en) 2001-06-11 2006-08-25 Compounds
US11/509,989 US20070066599A1 (en) 2001-06-11 2006-08-25 New compounds
US11/510,324 US7572787B2 (en) 2001-06-11 2006-08-25 Substituted naphthalene sulfonamides
JP2009209444A JP2010013473A (en) 2001-06-11 2009-09-10 Substituted sulfonamide compound and its method of application as medicine for treatment of cns disorder, obesity, and diabetes mellitus type 2
US12/781,355 US20100222330A1 (en) 2001-06-11 2010-05-17 New Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102386A SE0102386D0 (en) 2001-07-03 2001-07-03 New compounds

Publications (1)

Publication Number Publication Date
SE0102386D0 true SE0102386D0 (en) 2001-07-03

Family

ID=20284728

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102386A SE0102386D0 (en) 2001-06-11 2001-07-03 New compounds

Country Status (1)

Country Link
SE (1) SE0102386D0 (en)

Similar Documents

Publication Publication Date Title
IS6971A (en) New compounds
IS7016A (en) New 4-anilinoquinoline-3-carboxamide
ATE402148T1 (en) SUBSTITUTED PYRIDINYLAMINES
DE50206892D1 (en) SUBSTITUTED IMIDAZOTRIAZINONE
DK1373228T3 (en) Substituted fluoroalkoxyphenylsulfonylureas
DE50213651D1 (en) SUBSTITUTED 4-AMINOCYCLOHEXANOLE
ATA18372001A (en) GELENKSBOLZENBAUEINHEIT
ATA13992002A (en) SCHLACKENGRANULIERUNGSANLAGE
DE60216967D1 (en) SUBSTITUTED CYCLOHEXANDERIVATE
AT500276B8 (en) RADSCHWENKSYSTEM
SE0101958D0 (en) New compounds
SE0102386D0 (en) New compounds
SE0104366D0 (en) New compounds
SE0104342D0 (en) New compounds
SE0103461D0 (en) New compounds
SE0103437D0 (en) New compounds
SE0102056D0 (en) New Compounds
SE0101660D0 (en) New compounds
SE0101659D0 (en) New compounds
SE0100629D0 (en) New compounds
SE0100272D0 (en) New compounds
SE0100641D0 (en) Novel compounds
SE0103271D0 (en) Novel compounds
SE0104474D0 (en) Novel Compounds
SE0200704D0 (en) Novel compounds